Dr. Barley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
201 Sivley Rd SW
Huntsville, AL 35801Phone+1 256-265-1198Fax+1 256-265-1195
Education & Training
- Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2015 - 2018
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2012 - 2015
- Icahn School of Medicine at Mount SinaiClass of 2012
Certifications & Licensure
- AL State Medical License 2024 - 2025
- NY State Medical License 2015 - 2025
- TN State Medical License 2018 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsRegression of smoldering myeloma with treatment of Gaucher disease.Kevin Barley, Anshuman Parekh, Syed Salam, Damodara Rao Mendu, Ravi Prakash Shukla
Blood Advances. 2024-04-09 - 9 citationsImmunomodulatory drug- and proteasome inhibitor-backbone regimens in the treatment of relapsed multiple myeloma: an evidence-based review.Larysa Sanchez, Kevin Barley, Joshua Richter, Joseph K. Franz, Hearn Jay Cho
Expert Review of Hematology. 2020-08-30 - Recapturing disease response: A phase 2 study of carfilzomib 56 mg/m2 in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27 mg...Kevin Barley, Larysa Sanchez, Hearn Jay Cho, Samir Parekh, Deepu Madduri
American Journal of Hematology. 2020-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: